The “successful construction of hematopoietic bioreactors will have a tremendous impact on hematopoietic cell biology and on clinical practice. Such bioreactors would permit the production of mature blood cells, under controlled conditions, for transfusion therapy.”

"With over 30 million units of erythrocytes and over 10 million units of platelets transfused annually, this represents a tremendous demand on the health care system, and a extraordinary opportunity for bioengineering to circumvent the infectious hazards of volunteer donors."
- Emerson et al. J Cell Biochem. 45(3):268-72. 1991

Have A Question?

This is an important and hugely ambitious venture. Let us keep you posted on our progress.

Contact Us